Sanofi Pasteur to develop antibodies against infectious diseases

Tuesday 8 June 2010

Sanofi Pasteur has become the second European company in a month to invest in antibody technology in order to discover new treatments for infectious diseases. It is paying €3 million upfront to Vivalis of France for access to the technology.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

France